Premium
Phase II clinical trial of one dose of post‐transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched‐unrelated donor transplantation
Author(s) -
Jamy Omer,
InnisShelton Raquel,
Bal Susan,
Paluri Ravi,
Salzman Donna,
Di Stasi Antonio,
Costa Luciano,
Meredith Ruby,
Lamb Lawrence,
Minagawa Kentaro,
Mineishi Shin,
Saad Ayman
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26296
Subject(s) - medicine , graft versus host disease , cyclophosphamide , immunology , calcineurin , hematopoietic stem cell transplantation , transplantation , tacrolimus , gastroenterology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom